BackgroundThere are few data describing the longitudinal use of and adherence to heart failure medications following left ventricular assist device (LVAD) implantation.
Nicholas Y. Tan +3 more
doaj +1 more source
Significance of right ventricular function for the outcome of treatment and remodeling of the heart after left ventricular assist device implantation [PDF]
The efficiency of the device for permanent circulatory support of the left ventricle has been proven through clinical practice with the trend of constant improvement of treatment results along with biotechnological progress and improvement of surgical ...
Terzić Duško, Mikić Aleksandar
doaj
Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients The ROADMAP Study 2-Year Results [PDF]
OBJECTIVES The authors sought to provide the pre-specified primary endpoint of the ROADMAP (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients) trial at 2 years ...
Boyle, Andrew J. +15 more
core +2 more sources
Synergistic Model of Cardiac Function with a Heart Assist Device [PDF]
The breakdown of cardiac self-organization leads to heart diseases and failure, the number one cause of death worldwide. The left ventricular pressure–volume relation plays a key role in the diagnosis and treatment of heart diseases.
Bestel, Haken, Knudsen, Simaan, Tuzun
core +2 more sources
LVAD Vasculitis Case Series: Suggestion of a New Fatal LVAD-Related Phenomenon.
Left ventricular assist devices (LVADs) are surgically implanted mechanical devices indicated for patients with advanced heart failure and are known to come with several complications. Here we present a case series, and review 1 documented report, of LVAD vasculitis, a presumed new LVAD immune/humoral related phenomenon. (Level of Difficulty: Advanced.)
Garcia, Raul Angel +9 more
openaire +3 more sources
Left ventricular assist device implantation and concomitant aortic valve replacement [PDF]
Introduction. The implantable device for mechanical support of the left ventricular circulation (LVAD) is widely applied as a therapeutic option for survival and improvement of the quality of life in patients with the end-stage heart failure.
Mikić Aleksandar +4 more
doaj +1 more source
The use of a left ventricular assist device (LVAD) as a bridge-to-transplantation or destination therapy to support cardiac function in patients with end-stage heart failure (HF) is increasing in all developed countries.
Matteo Cameli +15 more
doaj +1 more source
Surgical treatment of the left ventricular assist device drive line infection with abscess formation [PDF]
Specific left ventricular assist device infections are the leading cause of morbidity and second most common cause of death in patients who survive the first six months after implanting device, and also they are the most common cause of readmissions to ...
Terzic Duško +6 more
doaj
Intermediate-Term Risk of Stroke Following Cardiac Procedures in a Nationally Representative Data Set. [PDF]
BACKGROUND: Studies on stroke risk following cardiac procedures addressed only perioperative and long-term risk following limited higher-risk procedures, were poorly generalizable, and often failed to stratify by stroke type. We calculated stroke risk in
Dhamoon, Amit S. +5 more
core +2 more sources
Left ventricular assist device implantation as bridge to heart transplantation [PDF]
Heart transplantation is a method of choice for the surgical treatment of a terminal stage of cardiac insufficiency. The lack of donors that all health systems in the world are experiencing has led to the intensive development of devices for permanent ...
Terzić Duško +4 more
doaj

